Haemonetics share price today
(NASDAQ: HAE)

Name: Haemonetics Share Price Today (NASDAQ: HAE) - Haemonetics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Haemonetics share price is $72.86 & ₹6,301.66 as on 24 Jan 2025, 2.30 'hrs' IST

$72.86

▲

-0.49

(-0.67%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Haemonetics share price in Dollar and Rupees. Guide to invest in Haemonetics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Haemonetics, along with analyst recommendations, forecasts, and comprehensive financials.

Haemonetics share price movements

Today's Low: $72.00
Today's High: $73.54
$72.86
1.18%
Downside
Day's Volatility :2.09%
Upside
0.92%
52 Weeks Low: $69.29
52 Weeks High: $97.97
$72.86
4.9%
Downside
52 Weeks Volatility :29.27%
Upside
25.63%

Haemonetics Returns

Period	Haemonetics Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.92%	-5.5%	0.0%
6 Months	-19.45%	-4.3%	0.0%
1 Year	-9.7%	1.6%	0.0%
3 Years	48.99%	9.8%	-11.0%

Haemonetics Key Statistics

in dollars & INR

Previous Close	$73.35
Open	$73.07
Today's High	$73.535
Today's Low	$72.0
Market Capitalization	$3.8B
Today's Volume	$531.8K
52 Week High	$97.97
52 Week Low	$69.29
Revenue TTM	$1.4B
EBITDA	$314.2M
Earnings Per Share (EPS)	$2.41
PE Ratio	31.22
Profit Margin	9.1%
Quarterly Earnings Growth YOY	0.38%
Return On Equity TTM	13.97%

How to invest in Haemonetics Stock (HAE) from India?

It is very easy for Indian residents to invest directly in Haemonetics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Haemonetics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Haemonetics or HAE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Haemonetics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Haemonetics shares which would translate to 0.012 fractional shares of Haemonetics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Haemonetics, in just a few clicks!

Returns in Haemonetics for Indian investors in Rupees

Investment Value

₹1,00,000

Haemonetics investment value today

Current value as on today

₹93,750

Returns

₹6,250

(-6.25%)

Returns from Haemonetics Stock

₹10,304 (-10.3%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Haemonetics

400%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Haemonetics on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 400% more investors are searching Haemonetics in the last 30 days versus the previous period.

Global Institutional Holdings in Haemonetics

BlackRock Inc
12.37%
Vanguard Group Inc
10.29%
Capital Research Global Investors
8.85%
Wellington Management Company LLP
8.37%
Neuberger Berman Group LLC
8.02%
T. Rowe Price Investment Management,Inc.
5.68%

Analyst Recommendation on Haemonetics

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Haemonetics(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Haemonetics

What analysts predicted

Upside of 52.07%

Target:

$110.80

Current:

$72.86

Insights on Haemonetics

Price Movement
In the last 3 years, HAE stock has moved up by 49.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 336.17M → 345.51M (in $), with an average increase of 2.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 38.37M → 33.83M (in $), with an average decrease of 11.8% per quarter
HAE vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 64.4% return, outperforming this stock by 76.8%
HAE vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 126.5% return, outperforming this stock by 77.0%
Price to Sales
ForHAE every $1 of sales, investors are willing to pay $2.7, whereas for Intuitive Surgical, Inc., the investors are paying $27.5 for every $1 of sales.

Haemonetics Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$967.6M	↑ 7.04%
Net Income	$55.0M	↑ 20.73%
Net Profit Margin	5.69%	↑ 0.65%

	FY20	Y/Y Change
Revenue	$988.5M	↑ 2.16%
Net Income	$76.5M	↑ 39.09%
Net Profit Margin	7.74%	↑ 2.05%

	FY21	Y/Y Change
Revenue	$870.5M	↓ 11.94%
Net Income	$79.5M	↑ 3.85%
Net Profit Margin	9.13%	↑ 1.39%

	FY22	Y/Y Change
Revenue	$993.2M	↑ 14.1%
Net Income	$43.4M	↓ 45.42%
Net Profit Margin	4.37%	↓ 4.76%

	FY23	Y/Y Change
Revenue	$1.2B	↑ 17.67%
Net Income	$115.4M	↑ 166.05%
Net Profit Margin	9.87%	↑ 5.5%

	FY24	Y/Y Change
Revenue	$1.3B	↑ 12.01%
Net Income	$117.6M	↑ 1.87%
Net Profit Margin	8.98%	↓ 0.89%

	Q2 FY23	Q/Q Change
Revenue	$311.3M	↑ 2.27%
Net Income	$41.0M	↑ 39.68%
Net Profit Margin	13.18%	↑ 3.53%

	Q3 FY23	Q/Q Change
Revenue	$318.2M	↑ 2.2%
Net Income	$24.9M	↓ 39.31%
Net Profit Margin	7.83%	↓ 5.35%

	Q4 FY23	Q/Q Change
Revenue	$336.3M	↑ 5.68%
Net Income	$31.2M	↑ 25.43%
Net Profit Margin	9.29%	↑ 1.46%

	Q1 FY24	Q/Q Change
Revenue	$343.3M	↑ 2.09%
Net Income	$20.4M	↓ 34.81%
Net Profit Margin	5.93%	↓ 3.36%

	Q2 FY24	Q/Q Change
Revenue	$336.2M	↓ 2.07%
Net Income	$38.4M	↑ 88.41%
Net Profit Margin	11.41%	↑ 5.48%

	Q3 FY24	Q/Q Change
Revenue	$345.5M	↑ 2.78%
Net Income	$33.8M	↓ 11.84%
Net Profit Margin	9.79%	↓ 1.62%

	FY19	Y/Y Change
Profit	$417.5M	↑ 1.37%

	FY20	Y/Y Change
Profit	$484.5M	↑ 16.04%

	FY21	Y/Y Change
Profit	$397.8M	↓ 17.89%

	FY22	Y/Y Change
Profit	$505.5M	↑ 27.06%

	FY23	Y/Y Change
Profit	$615.1M	↑ 21.68%

	FY24	Y/Y Change
Profit	$691.5M	↑ 12.43%

	Q2 FY23	Q/Q Change
Profit	$167.3M	↑ 7.05%

	Q3 FY23	Q/Q Change
Profit	$170.5M	↑ 1.94%

	Q4 FY23	Q/Q Change
Profit	$177.9M	↑ 4.31%

	Q1 FY24	Q/Q Change
Profit	$171.6M	↓ 3.52%

	Q2 FY24	Q/Q Change
Profit	$166.8M	↓ 2.79%

	Q3 FY24	Q/Q Change
Profit	$187.4M	↑ 12.36%

	FY19	Y/Y Change
Operating Cash Flow	$159.3M	↓ 27.71%
Investing Cash Flow	$-116.1M	↑ 84.24%
Financing Cash Flow	$-50.6M	↓ 58.03%

	FY20	Y/Y Change
Operating Cash Flow	$158.2M	↓ 0.67%
Investing Cash Flow	$-57.2M	↓ 50.77%
Financing Cash Flow	$-131.2M	↑ 159.16%

	FY21	Y/Y Change
Operating Cash Flow	$108.8M	↓ 31.23%
Investing Cash Flow	$-425.4M	↑ 644.09%
Financing Cash Flow	$367.5M	↓ 380.05%

	FY22	Y/Y Change
Operating Cash Flow	$172.3M	↑ 58.32%
Investing Cash Flow	$-86.3M	↓ 79.7%
Financing Cash Flow	$-15.7M	↓ 104.29%

	FY23	Y/Y Change
Operating Cash Flow	$273.1M	↑ 58.51%
Investing Cash Flow	$-143.8M	↑ 66.53%
Financing Cash Flow	$-100.4M	↑ 537.27%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$19.1M	↓ 76.03%
Investing Cash Flow	$-15.3M	↓ 15.24%
Financing Cash Flow	$-598.0K	↓ 62.69%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$99.1M	↑ 419.35%
Investing Cash Flow	$-25.1M	↑ 64.7%
Financing Cash Flow	$-7.2M	↑ 1099.33%

Haemonetics Technicals Summary

Sell

Neutral

Buy

Haemonetics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Haemonetics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Haemonetics Corp	-5.24%	-19.45%	-9.7%	48.99%	-31.58%
Intuitive Surgical, Inc.	13.67%	38.33%	62.8%	131.11%	222.7%
Alcon Ag	3.14%	-4.92%	16.36%	19.6%	45.42%
West Pharmaceutical Services Inc	4.54%	22.16%	-1.79%	-8.06%	123.72%
Resmed Inc.	6.34%	25.52%	32.72%	6.53%	53.98%
Becton, Dickinson And Company	4.83%	0.26%	0.57%	-7.82%	-14.95%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Haemonetics Corp	31.22	31.22	1.19	4.59	0.14	0.06	NA	17.44
Intuitive Surgical, Inc.	97.13	97.13	4.38	6.92	0.16	0.08	NA	43.75
Alcon Ag	37.84	37.84	3.21	3.03	0.06	0.03	0.0	43.25
West Pharmaceutical Services Inc	51.22	51.22	6.28	6.63	0.18	0.1	0.0	37.96
Resmed Inc.	32.91	32.91	1.82	9.35	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	40.67	40.67	1.09	14.35	0.06	0.03	0.02	89.47

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Haemonetics Corp	Buy	$3.8B	-31.58%	31.22	9.1%
Intuitive Surgical, Inc.	Buy	$215.2B	222.7%	97.13	28.51%
Alcon Ag	Buy	$44.2B	45.42%	37.84	11.89%
West Pharmaceutical Services Inc	Buy	$25.0B	123.72%	51.22	17.37%
Resmed Inc.	Buy	$36.4B	53.98%	32.91	23.15%
Becton, Dickinson And Company	Buy	$69.0B	-14.95%	40.67	7.13%

About Haemonetics

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Organization	Haemonetics
Employees	3657
CEO	Mr. Christopher A. Simon
Industry	Health Technology

Management People of Haemonetics

Name	Title
Mr. Christopher A. Simon	CEO, President & Director
Mr. James C. D'Arecca CPA	CFO, Executive VP & Financial Officer
Ms. Michelle L. Basil J.D.	Executive VP, General Counsel & Secretary
Mr. Josep Lluis Llorens	Executive Vice President of Global Manufacturing & Supply Chain
Ms. Farris Maryanne Maunsell	VP, Chief Accounting Officer & Principal Accounting Officer
Ms. Olga Guyette	Senior Director of Investor Relations
Mr. Rajeev Varma	Senior Vice President of Strategy & Corporate Development
Ms. Laurie A. Miller	Senior VP & Chief Human Resources Officer
Dr. Jan Hartmann M.D.	Senior VP & Chief Medical Officer
Mr. Stewart W. Strong	President of Global Hospital

Important FAQs about investing in Haemonetics (HAE) from India :

What is Haemonetics share price today?

Haemonetics share price today stands at $72.86, Open: $73.07 ; Previous Close: $73.35 ; High: $73.54 ; Low: $72.00 ; 52 Week High: $97.97 ; 52 Week Low: $69.29. The stock opens at $73.07, after a previous close of $73.35. The stock reached a daily high of $73.54 and a low of $72.00, with a 52-week high of $97.97 and a 52-week low of $69.29.

Can Indians buy Haemonetics shares?

Yes, Indians can invest in the Haemonetics (HAE) from India.

With INDmoney, you can buy Haemonetics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Haemonetics at zero transaction cost.

How can I buy Haemonetics shares from India?

It is very easy to buy Haemonetics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Haemonetics be purchased?

Yes, you can buy fractional shares of Haemonetics with INDmoney app.

What are the documents required to start investing in Haemonetics stocks?

To start investing in Haemonetics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.